Aspartic acid
- Generic Name
- Aspartic acid
- Brand Names
- Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinisol 15, Olimel, Periolimel, Plenamine, Premasol, Primene, Prosol, Trophamine 10 %
- Drug Type
- Small Molecule
- Chemical Formula
- C4H7NO4
- CAS Number
- 56-84-8
- Unique Ingredient Identifier
- 30KYC7MIAI
- Background
One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
- Indication
There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.
- Associated Conditions
- -
- Associated Therapies
- Amino acid supplementation
Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL
- Conditions
- Interventions
- First Posted Date
- 2024-04-11
- Last Posted Date
- 2024-04-29
- Lead Sponsor
- First Affiliated Hospital of Zhejiang University
- Target Recruit Count
- 81
- Registration Number
- NCT06361329
- Locations
- 🇨🇳
The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the Gambia
- First Posted Date
- 2021-01-11
- Last Posted Date
- 2021-06-04
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 1200
- Registration Number
- NCT04703608
- Locations
- 🇬🇲
Mrcg@Lshtm, Fajara, Gambia
Treatment of BV With Donaxyl and a Molecular Test of Cure
- Conditions
- First Posted Date
- 2019-08-15
- Last Posted Date
- 2019-08-15
- Lead Sponsor
- Skaraborg Hospital
- Target Recruit Count
- 58
- Registration Number
- NCT04057482
A Study to Assess Current Standard Malaria Treatment Guidelines in the Republic of the Sudan
- First Posted Date
- 2015-10-30
- Last Posted Date
- 2017-02-01
- Lead Sponsor
- Menzies School of Health Research
- Target Recruit Count
- 320
- Registration Number
- NCT02592408
- Locations
- 🇸🇩
New Halfa Hospital, New Halfa, Kassalla, Sudan
🇸🇩Gizeria Slang Hospital, Khartoum, Sudan
Healthy Volunteer Pilot Study Using 3 Types of Modified Release Formulations of Firategrast to Investigate How Quickly Absorption From the Digestive System Takes Place.
- Conditions
- Interventions
- First Posted Date
- 2011-08-29
- Last Posted Date
- 2017-06-20
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 20
- Registration Number
- NCT01424462
- Locations
- 🇦🇺
GSK Investigational Site, Randwick, New South Wales, Australia
Treatment of High Risk Adult Acute Lymphoblastic Leukemia
- Conditions
- First Posted Date
- 2009-02-27
- Last Posted Date
- 2020-04-07
- Lead Sponsor
- PETHEMA Foundation
- Target Recruit Count
- 100
- Registration Number
- NCT00853008
- Locations
- 🇪🇸
Hospital Germans Trias i Pujol, Badalona, Spain
🇪🇸Clínica Teknon, Barcelona, Spain
🇪🇸Hospital de Fuenlabrada, Madrid, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.